Ayusar Healthcare & Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth %
- Profit Growth -6.78%
- Ebitda -6.78%
- Net Worth -49.88%
- Total Assets -0.54%
About Ayusar Healthcare & Pharma
Ayusar Healthcare & Pharma Private Limited (AHPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 October 2013 and has a history of 11 years and four months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Ayusar Pharma & Healthcare Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dharmit Shah, Pradeep Mishra, and Ravindra Mishra serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U36109MH2013PTC248943
-
Company No.
248943
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Oct 2013
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Ayusar Healthcare & Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmit Shah
|
Managing Director | 08-Oct-2013 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Pradeep Mishra
|
Director | 22-Aug-2016 | Current |
|
Ravindra Mishra
|
Director | 08-Oct-2013 | Current |
Financial Performance of Ayusar Healthcare & Pharma.
Ayusar Healthcare & Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 6.78% decrease in profit. The company's net worth observed a substantial decline by a decrease of 49.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ayusar Healthcare & Pharma?
In 2020, Ayusar Healthcare & Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Rajus Enterprise Private LimitedDharmit Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ayusar Healthcare & Pharma?
Unlock and access historical data on people associated with Ayusar Healthcare & Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ayusar Healthcare & Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ayusar Healthcare & Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
